|Quantity Discounts||1 - 9999|
|1 - 9999|
|1 - 9999|
A recent congressional investigation created a fake IRB and registered it with HHS. It also got a real IRB to approve a trial for a made-up product even though there were no data from animal testing and no description of the ingredients —crucial details for any clinical research.
How solid is your IRB, and will you pay for its mistakes?
Study sponsors that don’t make sure their IRBs are in compliance are gambling with the future of their products, running the risk of having the FDA shut down their trials or reject their applications.
But it’s not as simple as asking if an IRB is registered with the government. What documents do you need to review to determine if the IRB’s activities match its written SOPs? What is the role of the audit report? What can you learn from the way federal regulators perform audits? And how much responsibility for human subject protection falls on you?
In this 90-minute Encore presentation, human research protection experts Theresa Straut and Amy Schwarzhoff of respected IRB Chesapeake Research Review will explain to drug and device sponsors what their responsibilities are under the regulations, the key steps in auditing an IRB, what to look for and how to address shortcomings.
Sign up your entire team to listen in and discover:
Don’t use the wrong IRB and end up with a flawed study that could endanger your applications. Register now and you'll get an opportunity to ask your toughest questions during the Q&A session.
This presentation is a must for anyone charged with ensuring the integrity of their company’s clinical data, including:
Theresa Straut, BA, CIP, RAC, is executive director of IRB services at Chesapeake Research Review, Inc., where she is responsible for the IRB Operations, Compliance and Special Projects departments. Prior to joining Chesapeake Research Review, Inc., she was director of regulatory affairs for Quintiles, Inc., focusing on GCPs, IND and NDA submissions, as well as managing internal processes and SOPs.Amy Schwarzhoff, BS, CIP, is executive director of consulting services, for Chesapeake Research Review, Inc. She has worked with Chesapeake Research Review, Inc. since 1995 in consulting services, IRB operations and as an alternate IRB member. Amy currently directs Chesapeake Research Review, Inc.'s consulting services team in providing compliance audits, human research protections programs assessments, training and educational programs for institutions, IRBs and investigators and Association for the Accreditation of Human Research Protection Programs accreditation and reaccreditation support.
|Date:||May 11–29, 2009|
|Location:||Your office or conference room (no need to travel!)|
Gather your team for maximum benefit! Your investment is for one dial-in.
We accept American Express, Visa and MasterCard. Make checks payable to FDAnews.
Or, register by phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600
Registrations may not be cancelled. Please contact customer service to make any substitutions.
Interested in Becoming a Speaker?
We're always looking for industry leaders eager to share their expertise at an FDAnews audioconference, webinar or physical conference. Our seasoned speaker community includes executives in the pharmaceutical, medical device and clinical trial industries, regulatory affairs, quality control, compliance, healthcare and academia, as well as several former — and current — top FDA officials. Click here to complete our speaker opportunity form and have a representative contact you about future opportunities.
Copyright ©2018. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing